Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-12

AUTHORS

Toshiyuki Baba, Marimo Sato-Matsushita, Akira Kanamoto, Akihiko Itoh, Naoki Oyaizu, Yusuke Inoue, Yutaka Kawakami, Hideaki Tahara

ABSTRACT

BACKGROUND: The tumor associated antigen (TAA) gp100 was one of the first identified and has been used in clinical trials to treat melanoma patients. However, the gp100 epitope peptide restricted to HLA-A*2402 has not been extensively examined clinically due to the ethnic variations. Since it is the most common HLA Class I allele in the Japanese population, we performed a phase I clinical trial of cancer vaccination using the HLA-A*2402 gp100 peptide to treat patients with metastatic melanoma. METHODS: The phase I clinical protocol to test a HLA-A*2402 gp100 peptide-based cancer vaccine was designed to evaluate safety as the primary endpoint and was approved by The University of Tokyo Institutional Review Board. Information related to the immunologic and antitumor responses were also collected as secondary endpoints. Patients that were HLA-A*2402 positive with stage IV melanoma were enrolled according to the criteria set by the protocol and immunized with a vaccine consisting of epitope peptide (VYFFLPDHL, gp100-in4) emulsified with incomplete Freund's adjuvant (IFA) for the total of 4 times with two week intervals. Prior to each vaccination, peripheral blood mononuclear cells (PBMCs) were separated from the blood and stored at -80°C. The stored PBMCs were thawed and examined for the frequency of the peptide specific T lymphocytes by IFN-γ- ELISPOT and MHC-Dextramer assays. RESULTS: No related adverse events greater than grade I were observed in the six patients enrolled in this study. No clinical responses were observed in the enrolled patients although vitiligo was observed after the vaccination in two patients. Promotion of peptide specific immune responses was observed in four patients with ELISPOT assay. Furthermore, a significant increase of CD8+ gp100-in4+ CTLs was observed in all patients using the MHC-Dextramer assay. Cytotoxic T lymphocytes (CTLs) clones specific to gp100-in4 were successfully established from the PBMC of some patients and these CTL clones were capable of lysing the melanoma cell line, 888 mel, which endogenously expresses HLA-restricted gp100-in4. CONCLUSION: Our results suggest this HLA-restricted gp100-in4 peptide vaccination protocol was well-tolerated and can induce antigen-specific T-cell responses in multiple patients. Although no objective anti-tumor effects were observed, the effectiveness of this approach can be enhanced with the appropriate modifications. More... »

PAGES

84

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1479-5876-8-84

DOI

http://dx.doi.org/10.1186/1479-5876-8-84

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044036838

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20843377


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "B-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cancer Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytotoxicity, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epitopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HLA-A Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "gp100 Melanoma Antigen", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baba", 
        "givenName": "Toshiyuki", 
        "id": "sg:person.01253701637.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253701637.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sato-Matsushita", 
        "givenName": "Marimo", 
        "id": "sg:person.01322015037.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322015037.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanamoto", 
        "givenName": "Akira", 
        "id": "sg:person.0601735106.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601735106.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Itoh", 
        "givenName": "Akihiko", 
        "id": "sg:person.0650050306.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650050306.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Pathology and Laboratory Medicine, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oyaizu", 
        "givenName": "Naoki", 
        "id": "sg:person.0704531460.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704531460.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Radiology of Research Hospital, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Inoue", 
        "givenName": "Yusuke", 
        "id": "sg:person.010476276272.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010476276272.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Keio University", 
          "id": "https://www.grid.ac/institutes/grid.26091.3c", 
          "name": [
            "Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University, School of Medicine, 35 Shinano-machi, 160-8582, Shinjuku-city, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawakami", 
        "givenName": "Yutaka", 
        "id": "sg:person.0726462502.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726462502.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tahara", 
        "givenName": "Hideaki", 
        "id": "sg:person.011652510372.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011652510372.41"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1074-7613(95)80053-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000981002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.183.3.1185", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001748098"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.92.17.7976", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002355207"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0215(19980209)75:4<517::aid-ijc5>3.0.co;2-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005243316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.181.2.799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006121031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cji.0000195295.74104.ad", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010133668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cji.0000195295.74104.ad", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010133668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cji.0000195295.74104.ad", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010133668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.cji.0000195295.74104.ad", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010133668"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.91.9.3515", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012403531"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1815", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016473468", 
          "https://doi.org/10.1038/nrc1815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1815", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016473468", 
          "https://doi.org/10.1038/nrc1815"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0065-2776(06)90007-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017797873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.179.3.921", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018012670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1782", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018519640", 
          "https://doi.org/10.1038/nrc1782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1782", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018519640", 
          "https://doi.org/10.1038/nrc1782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.4565", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018563763"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0065-2776(08)60431-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019777787"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200211000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019994792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00002371-200211000-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019994792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0215(19990105)80:1<92::aid-ijc18>3.0.co;2-m", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022104194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-04-3759", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029820031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1150", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031579889", 
          "https://doi.org/10.1038/nri1150"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1150", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031579889", 
          "https://doi.org/10.1038/nri1150"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.178.2.489", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033051074"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.94.5.1914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033090823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199510193331603", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035849376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-0116", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036030083"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0215(19990827)82:5<669::aid-ijc9>3.0.co;2-#", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037897067"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2006.02.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037898031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.jid.5700545", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039092273", 
          "https://doi.org/10.1038/sj.jid.5700545"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0398-321", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042802949", 
          "https://doi.org/10.1038/nm0398-321"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2005.02.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043174786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.coi.2005.11.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043927089"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.180.1.35", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045042533"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1078/0171-9335-00423", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046735901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049278910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.91.14.6458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049481800"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.179.3.1005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051456584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1399-0039.1996.tb02520.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052814994"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000478-199805000-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060122584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000478-199805000-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060122584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000478-199805000-00011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060122584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00003226-200005001-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060170035"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00003226-200005001-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060170035"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00003226-200005001-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060170035"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00003226-200005001-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060170035"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1840703", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062509891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.7652577", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062648309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074356006", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074558506", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074646622", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074892325", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077909606", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082473611", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082492411", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082723571", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082960813", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082972452", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083108787", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083245818", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083382586", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-12", 
    "datePublishedReg": "2010-12-01", 
    "description": "BACKGROUND: The tumor associated antigen (TAA) gp100 was one of the first identified and has been used in clinical trials to treat melanoma patients. However, the gp100 epitope peptide restricted to HLA-A*2402 has not been extensively examined clinically due to the ethnic variations. Since it is the most common HLA Class I allele in the Japanese population, we performed a phase I clinical trial of cancer vaccination using the HLA-A*2402 gp100 peptide to treat patients with metastatic melanoma.\nMETHODS: The phase I clinical protocol to test a HLA-A*2402 gp100 peptide-based cancer vaccine was designed to evaluate safety as the primary endpoint and was approved by The University of Tokyo Institutional Review Board. Information related to the immunologic and antitumor responses were also collected as secondary endpoints. Patients that were HLA-A*2402 positive with stage IV melanoma were enrolled according to the criteria set by the protocol and immunized with a vaccine consisting of epitope peptide (VYFFLPDHL, gp100-in4) emulsified with incomplete Freund's adjuvant (IFA) for the total of 4 times with two week intervals. Prior to each vaccination, peripheral blood mononuclear cells (PBMCs) were separated from the blood and stored at -80\u00b0C. The stored PBMCs were thawed and examined for the frequency of the peptide specific T lymphocytes by IFN-\u03b3- ELISPOT and MHC-Dextramer assays.\nRESULTS: No related adverse events greater than grade I were observed in the six patients enrolled in this study. No clinical responses were observed in the enrolled patients although vitiligo was observed after the vaccination in two patients. Promotion of peptide specific immune responses was observed in four patients with ELISPOT assay. Furthermore, a significant increase of CD8+ gp100-in4+ CTLs was observed in all patients using the MHC-Dextramer assay. Cytotoxic T lymphocytes (CTLs) clones specific to gp100-in4 were successfully established from the PBMC of some patients and these CTL clones were capable of lysing the melanoma cell line, 888 mel, which endogenously expresses HLA-restricted gp100-in4.\nCONCLUSION: Our results suggest this HLA-restricted gp100-in4 peptide vaccination protocol was well-tolerated and can induce antigen-specific T-cell responses in multiple patients. Although no objective anti-tumor effects were observed, the effectiveness of this approach can be enhanced with the appropriate modifications.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1479-5876-8-84", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6006580", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1032886", 
        "issn": [
          "1479-5876"
        ], 
        "name": "Journal of Translational Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402", 
    "pagination": "84", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d1c324afa203d81c0c5719c2a9cfc7a4f853599b4c58eccf287df4685733cd31"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20843377"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101190741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1479-5876-8-84"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044036838"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1479-5876-8-84", 
      "https://app.dimensions.ai/details/publication/pub.1044036838"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000551.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1479-5876-8-84"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-8-84'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-8-84'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-8-84'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-8-84'


 

This table displays all metadata directly associated to this object as RDF triples.

330 TRIPLES      21 PREDICATES      95 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1479-5876-8-84 schema:about N0162e278d80f439c9bd842810a08553e
2 N0735dd31ba3a48de86781c430ad8d7a8
3 N297e8a268ff64798ae41bd4aa2218984
4 N41354a034dff411e92419a2b39ca3451
5 N6a6ea3f3cf09417f8454a5399bbc95dc
6 N76c824c95118482b80b069e5864becd4
7 N82be3ee5359d433cb8cdad9a8c14c225
8 N91d08fe8d1c6467087f43bb05364d3eb
9 Na581ee0a16ad4073a8d0e46e113a800c
10 Nadc53d8886924eadb0f24310502acb1f
11 Nc6d383344b8f4b63abf9f532ee046c5e
12 Nccb4757407d7494f8c8f2c8027ffe3c0
13 Nd05ea778289d4801b46ee27c26908626
14 Nd14e88d6795046abaf1f0d5e4a5661f9
15 Nf3f0cb3a185f4533988126a8a034c9c7
16 Nf425e117a1814c5da4ce212a94537e35
17 anzsrc-for:11
18 anzsrc-for:1107
19 schema:author N896b178169354cf485828266e7bde82f
20 schema:citation sg:pub.10.1038/nm0398-321
21 sg:pub.10.1038/nrc1782
22 sg:pub.10.1038/nrc1815
23 sg:pub.10.1038/nri1150
24 sg:pub.10.1038/sj.jid.5700545
25 https://app.dimensions.ai/details/publication/pub.1074356006
26 https://app.dimensions.ai/details/publication/pub.1074558506
27 https://app.dimensions.ai/details/publication/pub.1074646622
28 https://app.dimensions.ai/details/publication/pub.1074892325
29 https://app.dimensions.ai/details/publication/pub.1077909606
30 https://app.dimensions.ai/details/publication/pub.1082473611
31 https://app.dimensions.ai/details/publication/pub.1082492411
32 https://app.dimensions.ai/details/publication/pub.1082723571
33 https://app.dimensions.ai/details/publication/pub.1082960813
34 https://app.dimensions.ai/details/publication/pub.1082972452
35 https://app.dimensions.ai/details/publication/pub.1083108787
36 https://app.dimensions.ai/details/publication/pub.1083245818
37 https://app.dimensions.ai/details/publication/pub.1083382586
38 https://doi.org/10.1002/(sici)1097-0215(19980209)75:4<517::aid-ijc5>3.0.co;2-w
39 https://doi.org/10.1002/(sici)1097-0215(19990105)80:1<92::aid-ijc18>3.0.co;2-m
40 https://doi.org/10.1002/(sici)1097-0215(19990827)82:5<669::aid-ijc9>3.0.co;2-#
41 https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6
42 https://doi.org/10.1016/j.ccr.2005.02.013
43 https://doi.org/10.1016/j.cell.2006.02.016
44 https://doi.org/10.1016/j.coi.2005.11.013
45 https://doi.org/10.1016/s0065-2776(06)90007-8
46 https://doi.org/10.1016/s0065-2776(08)60431-9
47 https://doi.org/10.1016/s1074-7613(95)80053-0
48 https://doi.org/10.1056/nejm199510193331603
49 https://doi.org/10.1073/pnas.91.14.6458
50 https://doi.org/10.1073/pnas.91.9.3515
51 https://doi.org/10.1073/pnas.92.17.7976
52 https://doi.org/10.1073/pnas.94.5.1914
53 https://doi.org/10.1078/0171-9335-00423
54 https://doi.org/10.1084/jem.178.2.489
55 https://doi.org/10.1084/jem.179.3.1005
56 https://doi.org/10.1084/jem.179.3.921
57 https://doi.org/10.1084/jem.180.1.35
58 https://doi.org/10.1084/jem.181.2.799
59 https://doi.org/10.1084/jem.183.3.1185
60 https://doi.org/10.1097/00000478-199805000-00011
61 https://doi.org/10.1097/00002371-200211000-00002
62 https://doi.org/10.1097/00003226-200005001-00002
63 https://doi.org/10.1097/01.cji.0000195295.74104.ad
64 https://doi.org/10.1111/j.1399-0039.1996.tb02520.x
65 https://doi.org/10.1126/science.1840703
66 https://doi.org/10.1126/science.7652577
67 https://doi.org/10.1158/0008-5472.can-04-3759
68 https://doi.org/10.1158/1078-0432.ccr-08-0116
69 https://doi.org/10.1200/jco.2006.09.4565
70 schema:datePublished 2010-12
71 schema:datePublishedReg 2010-12-01
72 schema:description BACKGROUND: The tumor associated antigen (TAA) gp100 was one of the first identified and has been used in clinical trials to treat melanoma patients. However, the gp100 epitope peptide restricted to HLA-A*2402 has not been extensively examined clinically due to the ethnic variations. Since it is the most common HLA Class I allele in the Japanese population, we performed a phase I clinical trial of cancer vaccination using the HLA-A*2402 gp100 peptide to treat patients with metastatic melanoma. METHODS: The phase I clinical protocol to test a HLA-A*2402 gp100 peptide-based cancer vaccine was designed to evaluate safety as the primary endpoint and was approved by The University of Tokyo Institutional Review Board. Information related to the immunologic and antitumor responses were also collected as secondary endpoints. Patients that were HLA-A*2402 positive with stage IV melanoma were enrolled according to the criteria set by the protocol and immunized with a vaccine consisting of epitope peptide (VYFFLPDHL, gp100-in4) emulsified with incomplete Freund's adjuvant (IFA) for the total of 4 times with two week intervals. Prior to each vaccination, peripheral blood mononuclear cells (PBMCs) were separated from the blood and stored at -80°C. The stored PBMCs were thawed and examined for the frequency of the peptide specific T lymphocytes by IFN-γ- ELISPOT and MHC-Dextramer assays. RESULTS: No related adverse events greater than grade I were observed in the six patients enrolled in this study. No clinical responses were observed in the enrolled patients although vitiligo was observed after the vaccination in two patients. Promotion of peptide specific immune responses was observed in four patients with ELISPOT assay. Furthermore, a significant increase of CD8+ gp100-in4+ CTLs was observed in all patients using the MHC-Dextramer assay. Cytotoxic T lymphocytes (CTLs) clones specific to gp100-in4 were successfully established from the PBMC of some patients and these CTL clones were capable of lysing the melanoma cell line, 888 mel, which endogenously expresses HLA-restricted gp100-in4. CONCLUSION: Our results suggest this HLA-restricted gp100-in4 peptide vaccination protocol was well-tolerated and can induce antigen-specific T-cell responses in multiple patients. Although no objective anti-tumor effects were observed, the effectiveness of this approach can be enhanced with the appropriate modifications.
73 schema:genre research_article
74 schema:inLanguage en
75 schema:isAccessibleForFree true
76 schema:isPartOf N2652b36d1dc14cf38257cb5c26387882
77 N71ca8379c1b94d309055a3a63f1b2af5
78 sg:journal.1032886
79 schema:name Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402
80 schema:pagination 84
81 schema:productId N2c2d57d4d3ee4a3eba56d74d005aea07
82 N3eeb777b3c414e1eacc14bf6a2909e62
83 Nbb71bbf04df0499b91364431e9facb4a
84 Nbfaca7ea03cb4ba7a7c061c0a9f9568f
85 Nc0542e4c2d884431a1d23bc1a4e25b45
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044036838
87 https://doi.org/10.1186/1479-5876-8-84
88 schema:sdDatePublished 2019-04-10T15:58
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N6e104815c1464b1583b3cb94e609d1c7
91 schema:url http://link.springer.com/10.1186%2F1479-5876-8-84
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N015dc12a2b314ff6aa26000ca8cf98a3 rdf:first sg:person.0704531460.54
96 rdf:rest Nf93c2e5ecaf54942ac900d8363a62efb
97 N0162e278d80f439c9bd842810a08553e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Antigens, Neoplasm
99 rdf:type schema:DefinedTerm
100 N0735dd31ba3a48de86781c430ad8d7a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Adult
102 rdf:type schema:DefinedTerm
103 N25b3aff8b294413d943b5a04da596ad2 rdf:first sg:person.0601735106.32
104 rdf:rest N9d58d9ef94044d8b84f8bf5e98382899
105 N2652b36d1dc14cf38257cb5c26387882 schema:volumeNumber 8
106 rdf:type schema:PublicationVolume
107 N297e8a268ff64798ae41bd4aa2218984 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Epitopes
109 rdf:type schema:DefinedTerm
110 N2c2d57d4d3ee4a3eba56d74d005aea07 schema:name dimensions_id
111 schema:value pub.1044036838
112 rdf:type schema:PropertyValue
113 N33dbbff1b13e4c76919ecfbb82c2d3e3 rdf:first sg:person.011652510372.41
114 rdf:rest rdf:nil
115 N3eeb777b3c414e1eacc14bf6a2909e62 schema:name pubmed_id
116 schema:value 20843377
117 rdf:type schema:PropertyValue
118 N41354a034dff411e92419a2b39ca3451 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name B-Lymphocytes
120 rdf:type schema:DefinedTerm
121 N5cddd3dd472b436f9c43801b7fff143b rdf:first sg:person.0726462502.04
122 rdf:rest N33dbbff1b13e4c76919ecfbb82c2d3e3
123 N6a6ea3f3cf09417f8454a5399bbc95dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Melanoma
125 rdf:type schema:DefinedTerm
126 N6e104815c1464b1583b3cb94e609d1c7 schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 N71ca8379c1b94d309055a3a63f1b2af5 schema:issueNumber 1
129 rdf:type schema:PublicationIssue
130 N76c824c95118482b80b069e5864becd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name HLA-A Antigens
132 rdf:type schema:DefinedTerm
133 N82be3ee5359d433cb8cdad9a8c14c225 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Immunohistochemistry
135 rdf:type schema:DefinedTerm
136 N896b178169354cf485828266e7bde82f rdf:first sg:person.01253701637.18
137 rdf:rest Nbdbcae8c29844f1da72dba21821a6460
138 N91d08fe8d1c6467087f43bb05364d3eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Cancer Vaccines
140 rdf:type schema:DefinedTerm
141 N9d58d9ef94044d8b84f8bf5e98382899 rdf:first sg:person.0650050306.21
142 rdf:rest N015dc12a2b314ff6aa26000ca8cf98a3
143 Na581ee0a16ad4073a8d0e46e113a800c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Middle Aged
145 rdf:type schema:DefinedTerm
146 Nadc53d8886924eadb0f24310502acb1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Humans
148 rdf:type schema:DefinedTerm
149 Nbb71bbf04df0499b91364431e9facb4a schema:name readcube_id
150 schema:value d1c324afa203d81c0c5719c2a9cfc7a4f853599b4c58eccf287df4685733cd31
151 rdf:type schema:PropertyValue
152 Nbdbcae8c29844f1da72dba21821a6460 rdf:first sg:person.01322015037.03
153 rdf:rest N25b3aff8b294413d943b5a04da596ad2
154 Nbfaca7ea03cb4ba7a7c061c0a9f9568f schema:name nlm_unique_id
155 schema:value 101190741
156 rdf:type schema:PropertyValue
157 Nc0542e4c2d884431a1d23bc1a4e25b45 schema:name doi
158 schema:value 10.1186/1479-5876-8-84
159 rdf:type schema:PropertyValue
160 Nc6d383344b8f4b63abf9f532ee046c5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Cytotoxicity, Immunologic
162 rdf:type schema:DefinedTerm
163 Nccb4757407d7494f8c8f2c8027ffe3c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Male
165 rdf:type schema:DefinedTerm
166 Nd05ea778289d4801b46ee27c26908626 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Neoplasm Metastasis
168 rdf:type schema:DefinedTerm
169 Nd14e88d6795046abaf1f0d5e4a5661f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Aged
171 rdf:type schema:DefinedTerm
172 Nf3f0cb3a185f4533988126a8a034c9c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name gp100 Melanoma Antigen
174 rdf:type schema:DefinedTerm
175 Nf425e117a1814c5da4ce212a94537e35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Female
177 rdf:type schema:DefinedTerm
178 Nf93c2e5ecaf54942ac900d8363a62efb rdf:first sg:person.010476276272.43
179 rdf:rest N5cddd3dd472b436f9c43801b7fff143b
180 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
181 schema:name Medical and Health Sciences
182 rdf:type schema:DefinedTerm
183 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
184 schema:name Immunology
185 rdf:type schema:DefinedTerm
186 sg:grant.6006580 http://pending.schema.org/fundedItem sg:pub.10.1186/1479-5876-8-84
187 rdf:type schema:MonetaryGrant
188 sg:journal.1032886 schema:issn 1479-5876
189 schema:name Journal of Translational Medicine
190 rdf:type schema:Periodical
191 sg:person.010476276272.43 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
192 schema:familyName Inoue
193 schema:givenName Yusuke
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010476276272.43
195 rdf:type schema:Person
196 sg:person.011652510372.41 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
197 schema:familyName Tahara
198 schema:givenName Hideaki
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011652510372.41
200 rdf:type schema:Person
201 sg:person.01253701637.18 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
202 schema:familyName Baba
203 schema:givenName Toshiyuki
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01253701637.18
205 rdf:type schema:Person
206 sg:person.01322015037.03 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
207 schema:familyName Sato-Matsushita
208 schema:givenName Marimo
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322015037.03
210 rdf:type schema:Person
211 sg:person.0601735106.32 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
212 schema:familyName Kanamoto
213 schema:givenName Akira
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601735106.32
215 rdf:type schema:Person
216 sg:person.0650050306.21 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
217 schema:familyName Itoh
218 schema:givenName Akihiko
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650050306.21
220 rdf:type schema:Person
221 sg:person.0704531460.54 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
222 schema:familyName Oyaizu
223 schema:givenName Naoki
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704531460.54
225 rdf:type schema:Person
226 sg:person.0726462502.04 schema:affiliation https://www.grid.ac/institutes/grid.26091.3c
227 schema:familyName Kawakami
228 schema:givenName Yutaka
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726462502.04
230 rdf:type schema:Person
231 sg:pub.10.1038/nm0398-321 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042802949
232 https://doi.org/10.1038/nm0398-321
233 rdf:type schema:CreativeWork
234 sg:pub.10.1038/nrc1782 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018519640
235 https://doi.org/10.1038/nrc1782
236 rdf:type schema:CreativeWork
237 sg:pub.10.1038/nrc1815 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016473468
238 https://doi.org/10.1038/nrc1815
239 rdf:type schema:CreativeWork
240 sg:pub.10.1038/nri1150 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031579889
241 https://doi.org/10.1038/nri1150
242 rdf:type schema:CreativeWork
243 sg:pub.10.1038/sj.jid.5700545 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039092273
244 https://doi.org/10.1038/sj.jid.5700545
245 rdf:type schema:CreativeWork
246 https://app.dimensions.ai/details/publication/pub.1074356006 schema:CreativeWork
247 https://app.dimensions.ai/details/publication/pub.1074558506 schema:CreativeWork
248 https://app.dimensions.ai/details/publication/pub.1074646622 schema:CreativeWork
249 https://app.dimensions.ai/details/publication/pub.1074892325 schema:CreativeWork
250 https://app.dimensions.ai/details/publication/pub.1077909606 schema:CreativeWork
251 https://app.dimensions.ai/details/publication/pub.1082473611 schema:CreativeWork
252 https://app.dimensions.ai/details/publication/pub.1082492411 schema:CreativeWork
253 https://app.dimensions.ai/details/publication/pub.1082723571 schema:CreativeWork
254 https://app.dimensions.ai/details/publication/pub.1082960813 schema:CreativeWork
255 https://app.dimensions.ai/details/publication/pub.1082972452 schema:CreativeWork
256 https://app.dimensions.ai/details/publication/pub.1083108787 schema:CreativeWork
257 https://app.dimensions.ai/details/publication/pub.1083245818 schema:CreativeWork
258 https://app.dimensions.ai/details/publication/pub.1083382586 schema:CreativeWork
259 https://doi.org/10.1002/(sici)1097-0215(19980209)75:4<517::aid-ijc5>3.0.co;2-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1005243316
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1002/(sici)1097-0215(19990105)80:1<92::aid-ijc18>3.0.co;2-m schema:sameAs https://app.dimensions.ai/details/publication/pub.1022104194
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1002/(sici)1097-0215(19990827)82:5<669::aid-ijc9>3.0.co;2-# schema:sameAs https://app.dimensions.ai/details/publication/pub.1037897067
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049278910
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1016/j.ccr.2005.02.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043174786
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1016/j.cell.2006.02.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037898031
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1016/j.coi.2005.11.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043927089
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1016/s0065-2776(06)90007-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017797873
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1016/s0065-2776(08)60431-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019777787
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1016/s1074-7613(95)80053-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000981002
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1056/nejm199510193331603 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035849376
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1073/pnas.91.14.6458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049481800
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1073/pnas.91.9.3515 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012403531
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1073/pnas.92.17.7976 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002355207
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1073/pnas.94.5.1914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033090823
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1078/0171-9335-00423 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046735901
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1084/jem.178.2.489 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033051074
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1084/jem.179.3.1005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051456584
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1084/jem.179.3.921 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018012670
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1084/jem.180.1.35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045042533
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1084/jem.181.2.799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006121031
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1084/jem.183.3.1185 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001748098
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1097/00000478-199805000-00011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060122584
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1097/00002371-200211000-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019994792
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1097/00003226-200005001-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060170035
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1097/01.cji.0000195295.74104.ad schema:sameAs https://app.dimensions.ai/details/publication/pub.1010133668
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1111/j.1399-0039.1996.tb02520.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1052814994
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1126/science.1840703 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062509891
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1126/science.7652577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062648309
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1158/0008-5472.can-04-3759 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029820031
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1158/1078-0432.ccr-08-0116 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036030083
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1200/jco.2006.09.4565 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018563763
322 rdf:type schema:CreativeWork
323 https://www.grid.ac/institutes/grid.26091.3c schema:alternateName Keio University
324 schema:name Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University, School of Medicine, 35 Shinano-machi, 160-8582, Shinjuku-city, Tokyo, Japan
325 rdf:type schema:Organization
326 https://www.grid.ac/institutes/grid.26999.3d schema:alternateName University of Tokyo
327 schema:name Department of Pathology and Laboratory Medicine, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan
328 Department of Radiology of Research Hospital, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan
329 Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokane-dai, 108-8639, Minato-city, Tokyo, Japan
330 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...